Biogen, Inc. (BIIB)
169.31
-8.99
(-5.04%)
USD |
NASDAQ |
Jan 14, 16:00
169.99
+0.68
(+0.40%)
After-Hours: 07:10
Biogen Price: 169.31 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1073.29 |
| Stoke Therapeutics, Inc. | 30.97 |
| AbbVie, Inc. | 221.89 |
| Alnylam Pharmaceuticals, Inc. | 366.86 |
| Insmed, Inc. | 163.46 |
Price Related Metrics
| PE Ratio | 15.44 |
| PS Ratio | 2.562 |
| Price to Book Value | 1.364 |
| Price to Free Cash Flow | 10.97 |
| Earnings Yield | 6.48% |
| Market Cap | 24.84B |
| Operating PE Ratio | 10.18 |
| Normalized PE Ratio | 13.69 |